Neuromap and QPAN have significant implications for the treatment of autism spectrum disorder. By identifying dysregulated brain activity, such as excessive delta waves or low gamma power, these tools ...

EUR19.3 million investment from Impact Expansion and from existing neurocare shareholder TVM Capital Healthcare. This ...